Best for
Mobile

Posted
Tilray, Inc is a drug manufacturers-specialty & generic business based in the US. Tilray shares (TLRY.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $18.02 – a decrease of 8.53% over the previous week. Tilray employs 1,646 staff and has a trailing 12-month revenue of around $183.1 million.
Best for
Mobile
Best for
Low-cost
Best for
All rounder
Best for
Beginners
Latest market close | $18.02 |
---|---|
52-week range | $2.43 - $22.61 |
50-day moving average | $11.0545 |
200-day moving average | $7.7568 |
Wall St. target price | $10.31 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.23 |
Other fees may apply. Your capital is at risk.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of $18.02
1 week (2021-01-15) | -8.53% |
---|---|
1 month (2020-12-24) | 109.78% |
3 months (2020-10-23) | 167.76% |
6 months (2020-07-24) | 153.09% |
1 year (2020-01-24) | -8.76% |
---|---|
2 years (2019-01-24) | -75.64% |
Revenue TTM | $183.1 million |
---|---|
Gross profit TTM | $-21,455,000 |
Return on assets TTM | -15.13% |
Return on equity TTM | -161.76% |
Profit margin | -266.12% |
Book value | $1.401 |
Market capitalisation | $2.9 billion |
TTM: trailing 12 months
There are currently 27.7 million Tilray shares held short by investors – that's known as Tilray's "short interest". This figure is 3.3% up from 26.8 million last month.
There are a few different ways that this level of interest in shorting Tilray shares can be evaluated.
Tilray's "short interest ratio" (SIR) is the quantity of Tilray shares currently shorted divided by the average quantity of Tilray shares traded daily (recently around 21.3 million). Tilray's SIR currently stands at 1.3. In other words for every 100,000 Tilray shares traded daily on the market, roughly 1300 shares are currently held short.
However Tilray's short interest can also be evaluated against the total number of Tilray shares, or, against the total number of tradable Tilray shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tilray's short interest could be expressed as 0.18% of the outstanding shares (for every 100,000 Tilray shares in existence, roughly 180 shares are currently held short) or 0.1843% of the tradable shares (for every 100,000 tradable Tilray shares, roughly 184 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Tilray.
Find out more about how you can short Tilray stock.
We're not expecting Tilray to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, Tilray's shares have ranged in value from as little as $2.43 up to $22.61. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tilray's is 3.108. This would suggest that Tilray's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Subscribe to trending stock alerts for a chance to win
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, pharmacies, governments, and hospitals; and for researchers for commercial purposes, as well as compassionate access and clinical research applications. It operates in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, Israel, Ireland, New Zealand, South Africa, Switzerland, the United States, and the United Kingdom. The company was incorporated in 2018 and is headquartered in Nanaimo, Canada.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.